Chinese General Practice ›› 2022, Vol. 25 ›› Issue (32): 4085-4090.DOI: 10.12114/j.issn.1007-9572.2022.0382
• Article·Epidemiologic Research • Previous Articles Next Articles
Received:
2022-04-29
Revised:
2022-08-01
Published:
2022-11-15
Online:
2022-08-18
Contact:
LIU Gang
About author:
通讯作者:
刘刚
作者简介:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0382
时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类慢性病合计 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 占总死亡人数比例(%) | |
2014 | 46.79 | 77.22 | 1.26 | 2.57 | 25.34 | 44.40 | 1.94 | 3.57 | 75.33 | 127.76 | 77.20 |
2015 | 58.80 | 96.39 | 1.98 | 4.19 | 27.87 | 48.85 | 1.23 | 2.31 | 89.89 | 151.74 | 76.58 |
2016 | 52.71 | 89.16 | 3.38 | 6.40 | 24.87 | 41.88 | 2.78 | 5.11 | 83.73 | 142.55 | 79.35 |
2017 | 50.45 | 84.89 | 2.10 | 4.02 | 21.35 | 35.69 | 1.48 | 2.82 | 75.38 | 127.41 | 82.63 |
2018 | 50.51 | 87.20 | 2.15 | 3.95 | 21.84 | 37.27 | 1.93 | 3.55 | 76.43 | 131.98 | 82.01 |
2019 | 44.77 | 78.60 | 1.98 | 3.71 | 19.73 | 34.22 | 1.83 | 3.47 | 68.31 | 120.00 | 82.03 |
2020 | 47.38 | 82.16 | 2.07 | 4.01 | 21.34 | 37.67 | 1.49 | 2.90 | 72.28 | 126.74 | 81.81 |
APC(%) | -1.90 | -0.90 | 3.80 | 2.20 | -4.70 | -4.60 | -1.30 | -0.60 | -2.70 | -2.00 | 1.20 |
Z值 | -1.20 | -0.60 | 0.70 | 0.40 | -3.50 | -2.90 | -0.20 | -0.10 | -1.90 | -1.50 | 3.50 |
P值 | 0.290 | 0.600 | 0.540 | 0.710 | 0.017 | 0.032 | 0.821 | 0.909 | 0.119 | 0.201 | 0.020 |
Table 1 Yearly crude mortality rates and temporal trends of four major noncommunicable diseases among Shenzhen permanent residents aged 30-69 from 2014 to 2020
时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类慢性病合计 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 死亡率(1/10万) | 标化死亡率(1/10万) | 占总死亡人数比例(%) | |
2014 | 46.79 | 77.22 | 1.26 | 2.57 | 25.34 | 44.40 | 1.94 | 3.57 | 75.33 | 127.76 | 77.20 |
2015 | 58.80 | 96.39 | 1.98 | 4.19 | 27.87 | 48.85 | 1.23 | 2.31 | 89.89 | 151.74 | 76.58 |
2016 | 52.71 | 89.16 | 3.38 | 6.40 | 24.87 | 41.88 | 2.78 | 5.11 | 83.73 | 142.55 | 79.35 |
2017 | 50.45 | 84.89 | 2.10 | 4.02 | 21.35 | 35.69 | 1.48 | 2.82 | 75.38 | 127.41 | 82.63 |
2018 | 50.51 | 87.20 | 2.15 | 3.95 | 21.84 | 37.27 | 1.93 | 3.55 | 76.43 | 131.98 | 82.01 |
2019 | 44.77 | 78.60 | 1.98 | 3.71 | 19.73 | 34.22 | 1.83 | 3.47 | 68.31 | 120.00 | 82.03 |
2020 | 47.38 | 82.16 | 2.07 | 4.01 | 21.34 | 37.67 | 1.49 | 2.90 | 72.28 | 126.74 | 81.81 |
APC(%) | -1.90 | -0.90 | 3.80 | 2.20 | -4.70 | -4.60 | -1.30 | -0.60 | -2.70 | -2.00 | 1.20 |
Z值 | -1.20 | -0.60 | 0.70 | 0.40 | -3.50 | -2.90 | -0.20 | -0.10 | -1.90 | -1.50 | 3.50 |
P值 | 0.290 | 0.600 | 0.540 | 0.710 | 0.017 | 0.032 | 0.821 | 0.909 | 0.119 | 0.201 | 0.020 |
时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | ||||
---|---|---|---|---|---|---|---|---|
死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | |
2014 | 54.28 | 95.52 | 0.44 | 0.85 | 35.41 | 63.23 | 2.55 | 5.00 |
2015 | 73.44 | 73.44 | 0.93 | 1.80 | 42.69 | 76.46 | 1.77 | 3.57 |
2016 | 59.06 | 59.06 | 4.62 | 8.85 | 37.32 | 63.48 | 3.85 | 7.19 |
2017 | 56.48 | 101.69 | 2.34 | 4.51 | 32.27 | 53.50 | 2.26 | 4.43 |
2018 | 57.16 | 103.73 | 3.00 | 5.51 | 31.75 | 54.28 | 3.17 | 5.90 |
2019 | 50.18 | 93.51 | 2.69 | 4.97 | 29.09 | 50.42 | 2.69 | 5.41 |
2020 | 57.23 | 106.03 | 3.44 | 6.71 | 35.29 | 62.34 | 2.46 | 5.08 |
APC(%) | -2.20 | 5.00 | 32.40 | 31.90 | -3.30 | -3.60 | 1.90 | 2.50 |
Z值 | -1.00 | 1.20 | 2.40 | 2.40 | -1.60 | -1.50 | 0.40 | 0.60 |
P值 | 0.350 | 0.270 | 0.060 | 0.070 | 0.171 | 0.187 | 0.720 | 0.606 |
Table 2 Yearly crude mortality rates and temporal trends of four major noncommunicable diseases among Shenzhen male permanent residents aged 30-69 from 2014 to 2020
时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | ||||
---|---|---|---|---|---|---|---|---|
死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | |
2014 | 54.28 | 95.52 | 0.44 | 0.85 | 35.41 | 63.23 | 2.55 | 5.00 |
2015 | 73.44 | 73.44 | 0.93 | 1.80 | 42.69 | 76.46 | 1.77 | 3.57 |
2016 | 59.06 | 59.06 | 4.62 | 8.85 | 37.32 | 63.48 | 3.85 | 7.19 |
2017 | 56.48 | 101.69 | 2.34 | 4.51 | 32.27 | 53.50 | 2.26 | 4.43 |
2018 | 57.16 | 103.73 | 3.00 | 5.51 | 31.75 | 54.28 | 3.17 | 5.90 |
2019 | 50.18 | 93.51 | 2.69 | 4.97 | 29.09 | 50.42 | 2.69 | 5.41 |
2020 | 57.23 | 106.03 | 3.44 | 6.71 | 35.29 | 62.34 | 2.46 | 5.08 |
APC(%) | -2.20 | 5.00 | 32.40 | 31.90 | -3.30 | -3.60 | 1.90 | 2.50 |
Z值 | -1.00 | 1.20 | 2.40 | 2.40 | -1.60 | -1.50 | 0.40 | 0.60 |
P值 | 0.350 | 0.270 | 0.060 | 0.070 | 0.171 | 0.187 | 0.720 | 0.606 |
时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | ||||
---|---|---|---|---|---|---|---|---|
死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | |
2014 | 38.82 | 44.45 | 2.12 | 4.21 | 14.63 | 25.25 | 1.30 | 2.23 |
2015 | 43.20 | 65.76 | 3.10 | 6.42 | 12.07 | 20.56 | 0.66 | 1.07 |
2016 | 45.95 | 72.24 | 2.05 | 3.89 | 11.59 | 19.70 | 1.64 | 3.08 |
2017 | 44.02 | 69.05 | 1.85 | 3.46 | 9.71 | 17.16 | 0.65 | 1.21 |
2018 | 43.42 | 70.85 | 1.24 | 2.34 | 11.28 | 19.74 | 0.62 | 0.05 |
2019 | 39.01 | 64.26 | 1.23 | 2.42 | 9.75 | 17.40 | 0.90 | 1.55 |
2020 | 38.38 | 61.94 | 0.82 | 1.68 | 8.60 | 15.64 | 0.60 | 1.02 |
APC(%) | -1.00 | 3.40 | -17.00 | -17.00 | -7.10 | -6.10 | -9.10 | -18.50 |
Z值 | -0.70 | 1.10 | -4.80 | -4.70 | -4.70 | -4.10 | -1.30 | -0.80 |
P值 | 0.490 | 0.330 | 0.010 | 0.006 | 0.005 | 0.010 | 0.240 | 0.477 |
Table 3 Yearly crude mortality rates and temporal trends of four major noncommunicable diseases among Shenzhen female permanent residents aged 30-69 from 2014 to 2020
时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | ||||
---|---|---|---|---|---|---|---|---|
死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | 死亡率 | 标化死亡率 | |
2014 | 38.82 | 44.45 | 2.12 | 4.21 | 14.63 | 25.25 | 1.30 | 2.23 |
2015 | 43.20 | 65.76 | 3.10 | 6.42 | 12.07 | 20.56 | 0.66 | 1.07 |
2016 | 45.95 | 72.24 | 2.05 | 3.89 | 11.59 | 19.70 | 1.64 | 3.08 |
2017 | 44.02 | 69.05 | 1.85 | 3.46 | 9.71 | 17.16 | 0.65 | 1.21 |
2018 | 43.42 | 70.85 | 1.24 | 2.34 | 11.28 | 19.74 | 0.62 | 0.05 |
2019 | 39.01 | 64.26 | 1.23 | 2.42 | 9.75 | 17.40 | 0.90 | 1.55 |
2020 | 38.38 | 61.94 | 0.82 | 1.68 | 8.60 | 15.64 | 0.60 | 1.02 |
APC(%) | -1.00 | 3.40 | -17.00 | -17.00 | -7.10 | -6.10 | -9.10 | -18.50 |
Z值 | -0.70 | 1.10 | -4.80 | -4.70 | -4.70 | -4.10 | -1.30 | -0.80 |
P值 | 0.490 | 0.330 | 0.010 | 0.006 | 0.005 | 0.010 | 0.240 | 0.477 |
时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类慢性病合计 | |||||
---|---|---|---|---|---|---|---|---|---|---|
死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | |
2014 | 818 | 6.50 | 22 | 0.26 | 443 | 3.89 | 34 | 0.31 | 1 317 | 10.73 |
2015 | 1 097 | 7.80 | 37 | 0.43 | 520 | 4.29 | 23 | 0.23 | 1 677 | 12.45 |
2016 | 1 062 | 7.56 | 68 | 0.59 | 501 | 3.67 | 56 | 0.46 | 1 687 | 12.00 |
2017 | 1 127 | 7.21 | 47 | 0.37 | 477 | 3.12 | 33 | 0.28 | 1 684 | 10.77 |
2018 | 1 175 | 7.49 | 50 | 0.33 | 508 | 3.20 | 45 | 0.35 | 1 778 | 11.15 |
2019 | 1 128 | 6.74 | 50 | 0.33 | 497 | 2.96 | 46 | 0.33 | 1 721 | 10.17 |
2020 | 1 212 | 6.82 | 53 | 0.37 | 546 | 3.19 | 38 | 0.30 | 1 849 | 10.47 |
APC(%) | -0.60 | 0.10 | -5.10 | 1.40 | -1.90 | |||||
Z值 | -0.40 | 0.00 | -3.40 | 0.30 | -1.60 | |||||
P值 | 0.697 | 0.991 | 0.019 | 0.772 | 0.171 |
Table 4 Yearly probability of premature death from four major noncommunicable diseases and temporal trends among Shenzhen permanent residents aged 30-69 from 2014 to 2020
时间(年) | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类慢性病合计 | |||||
---|---|---|---|---|---|---|---|---|---|---|
死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | 死亡人数 | 早死概率(%) | |
2014 | 818 | 6.50 | 22 | 0.26 | 443 | 3.89 | 34 | 0.31 | 1 317 | 10.73 |
2015 | 1 097 | 7.80 | 37 | 0.43 | 520 | 4.29 | 23 | 0.23 | 1 677 | 12.45 |
2016 | 1 062 | 7.56 | 68 | 0.59 | 501 | 3.67 | 56 | 0.46 | 1 687 | 12.00 |
2017 | 1 127 | 7.21 | 47 | 0.37 | 477 | 3.12 | 33 | 0.28 | 1 684 | 10.77 |
2018 | 1 175 | 7.49 | 50 | 0.33 | 508 | 3.20 | 45 | 0.35 | 1 778 | 11.15 |
2019 | 1 128 | 6.74 | 50 | 0.33 | 497 | 2.96 | 46 | 0.33 | 1 721 | 10.17 |
2020 | 1 212 | 6.82 | 53 | 0.37 | 546 | 3.19 | 38 | 0.30 | 1 849 | 10.47 |
APC(%) | -0.60 | 0.10 | -5.10 | 1.40 | -1.90 | |||||
Z值 | -0.40 | 0.00 | -3.40 | 0.30 | -1.60 | |||||
P值 | 0.697 | 0.991 | 0.019 | 0.772 | 0.171 |
时间(年) | 男性 | 女性 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类主要慢性病合计 | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类主要慢性病合计 | |
2014 | 8.30 | 0.06 | 5.56 | 0.46 | 13.94 | 4.76 | 0.44 | 2.22 | 0.18 | 7.50 |
2015 | 10.60 | 0.14 | 6.69 | 0.36 | 17.09 | 5.05 | 0.69 | 1.87 | 0.09 | 7.59 |
2016 | 9.35 | 0.81 | 5.54 | 0.71 | 15.16 | 5.86 | 0.38 | 1.78 | 0.23 | 8.13 |
2017 | 8.87 | 0.40 | 4.66 | 0.45 | 13.64 | 5.65 | 0.32 | 1.57 | 0.12 | 7.58 |
2018 | 9.11 | 0.45 | 4.63 | 0.55 | 13.94 | 5.92 | 0.21 | 1.77 | 0.15 | 7.95 |
2019 | 8.29 | 0.45 | 4.27 | 0.52 | 12.78 | 5.28 | 0.21 | 1.63 | 0.15 | 7.19 |
2020 | 9.08 | 0.61 | 5.18 | 0.52 | 14.37 | 4.93 | 0.17 | 1.45 | 0.11 | 6.59 |
APC(%) | -0.90 | 38.00 | -4.50 | 3.20 | -2.00 | 0.70 | -18.70 | -5.40 | -3.50 | -1.80 |
Z值 | -0.50 | 2.40 | -2.00 | 0.80 | -1.20 | 0.40 | -4.80 | -4.10 | -0.60 | -1.60 |
P值 | 0.618 | 0.060 | 0.107 | 0.472 | 0.277 | 0.695 | 0.005 | 0.010 | 0.575 | 0.170 |
Table 5 Sex-based analysis of yearly probability of premature death from four major noncommunicable diseases and temporal trends among Shenzhen permanent residents aged 30-69 from 2014 to 2020
时间(年) | 男性 | 女性 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类主要慢性病合计 | 恶性肿瘤 | 糖尿病 | 心脑血管疾病 | 慢性呼吸系统疾病 | 4类主要慢性病合计 | |
2014 | 8.30 | 0.06 | 5.56 | 0.46 | 13.94 | 4.76 | 0.44 | 2.22 | 0.18 | 7.50 |
2015 | 10.60 | 0.14 | 6.69 | 0.36 | 17.09 | 5.05 | 0.69 | 1.87 | 0.09 | 7.59 |
2016 | 9.35 | 0.81 | 5.54 | 0.71 | 15.16 | 5.86 | 0.38 | 1.78 | 0.23 | 8.13 |
2017 | 8.87 | 0.40 | 4.66 | 0.45 | 13.64 | 5.65 | 0.32 | 1.57 | 0.12 | 7.58 |
2018 | 9.11 | 0.45 | 4.63 | 0.55 | 13.94 | 5.92 | 0.21 | 1.77 | 0.15 | 7.95 |
2019 | 8.29 | 0.45 | 4.27 | 0.52 | 12.78 | 5.28 | 0.21 | 1.63 | 0.15 | 7.19 |
2020 | 9.08 | 0.61 | 5.18 | 0.52 | 14.37 | 4.93 | 0.17 | 1.45 | 0.11 | 6.59 |
APC(%) | -0.90 | 38.00 | -4.50 | 3.20 | -2.00 | 0.70 | -18.70 | -5.40 | -3.50 | -1.80 |
Z值 | -0.50 | 2.40 | -2.00 | 0.80 | -1.20 | 0.40 | -4.80 | -4.10 | -0.60 | -1.60 |
P值 | 0.618 | 0.060 | 0.107 | 0.472 | 0.277 | 0.695 | 0.005 | 0.010 | 0.575 | 0.170 |
[1] |
|
[2] |
健康中国行动推进委员会. 健康中国行动(2019—2030年)[EB/OL]. [2022-06-26].
|
[3] |
深圳市政协.健康深圳行动计划(2017-2020年)[EB/OL]. [2022-06-26].
|
[4] |
王玲,陈伟文,张彩娟,等. 2015—2019年深圳市坪山区重要慢性病早死概率和去死因期望寿命分析[J]. 职业与健康,2021,37(9):1223-1227. DOI:10.13329/j.cnki.zyyjk.2021.0309.
|
[5] |
|
[6] |
|
[7] |
徐继英,李新建,姚海宏,等. 上海市成年人慢性病相关危险因素行为特征研究[J]. 中华预防医学杂志,2013,47(9):821-825. DOI:10.3760/cma.j.issn.0253-9624.2013.09.011.
|
[8] |
靳雅男,杨艺,谢帆,等. 2012—2016年宁夏心脑血管疾病死亡状况分析[J]. 中国慢性病预防与控制,2019,27(11):806-808,813. DOI:10.16386/j.cjpccd.issn.1004-6194.2019.11.002.
|
[9] |
雷智,张燕,刘霞,等. 四川省泸州市2017年心脑血管疾病死亡特征及疾病负担分析[J]. 现代预防医学,2019,46(18):3373-3376.
|
[10] |
陈亦晨,陈华,周弋,等. 2002—2020年上海市浦东新区居民主要慢性病早死概率研究[J]. 中国全科医学,2022,25(9):1098-1104. DOI:10.12114/j.issn.1007-9572.2021.02.074.
|
[11] |
杨梨丽,林启,王玉超,等. 2009—2018年舟山市4类主要慢性病早死概率及"健康中国2030"目标分析[J]. 中国慢性病预防与控制,2021,29(2):140-143. DOI:10.16386/j.cjpccd.issn.1004-6194.2021.02.014.
|
[12] |
刘倩云,钟定威,马敏杰,等. 2015—2019年中山市城区居民主要慢性病早死概率变化分析[J]. 中国公共卫生管理,2021,37(6):803-806. DOI:10.19568/j.cnki.23-1318.2021.06.0025.
|
[13] |
吕丽娜,陈楠. 2010—2017年天津市河东区主要慢性病早死率及其变化趋势[J]. 中国慢性病预防与控制,2020,28(1):74-77. DOI:10.16386/j.cjpccd.issn.1004-6194.2020.01.019.
|
[14] |
陈娜,邓静,雷群建,等. 2011—2019年重庆市长寿区4类主要慢性病早死概率及变化趋势[J]. 保健医学研究与实践,2021,18(5):30-34.
|
[15] |
陈培培,俞浩,娄培安,等. 2015—2019年徐州市主要慢性病过早死亡情况及变化趋势[J]. 中国慢性病预防与控制,2022,30(1):77-80. DOI:10.16386/j.cjpccd.issn.1004-6194.2022.01.019.
|
[16] |
国务院办公厅. 国务院办公厅关于印发中国防治慢性病中长期规划(2017—2025年)的通知[EB/OL]. [2022-03-17].
|
[17] |
丁贤彬,唐文革,焦艳,等. 2010—2016年重庆市4种主要慢性病早死率及其变化趋势[J]. 中国慢性病预防与控制,2017,25(9):641-645. DOI:10.16386/j.cjpccd.issn.1004-6194.2017.09.001.
|
[18] |
孙晓凯,刘付东,梁季,等. 2008—2017年盐城市主要慢性病死亡情况及其变化趋势分析[J]. 中国慢性病预防与控制,2019,27(4):314-317. DOI:10.16386/j.cjpccd.issn.1004-6194.2019.04.019.
|
[19] |
刘辉,丛革新,贾鑫. 2009—2018年天津市河北区主要慢性病过早死亡情况及其趋势分析[J]. 中国慢性病预防与控制,2021,29(8):639-642. DOI:10.16386/j.cjpccd.issn.1004-6194.2021.08.019.
|
[1] | XU Baichuan, WANG Yan, ZHANG Peng, LI Yiting, LIU Feilai, XIE Yang. Research and Analysis of Screening Tools for Chronic Obstructive Pulmonary Disease Comorbidity Lung Cancer [J]. Chinese General Practice, 2025, 28(30): 3847-3852. |
[2] | ZHOU Sheng, DENG Changsheng, ZOU Guanyang, SONG Jianping. Research Progress on the Pathogenesis of Complications of Malaria in Cardiovascular Diseases [J]. Chinese General Practice, 2025, 28(27): 3466-3472. |
[3] | ZHANG Yunuo, LI Ruibin, WANG Wei. Correlation Analysis of Serum Nesfatin-1 and Ghrelin Levels with Glycolipid Metabolism and Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(26): 3264-3270. |
[4] | ZHANG Ruimin, DONG Zheyi, LI Shuang, WANG Qian, CHEN Xiangmei. Traditional Chinese Medicine Factors Associated with Diabetic Nephropathy Diagnosed by Renal Biopsy [J]. Chinese General Practice, 2025, 28(26): 3307-3313. |
[5] | XIANG Xinyue, ZHANG Bingqing, OUYANG Yuqin, TANG Wenjuan, FENG Wenhuan. Impact of Short-term Medical Weight Loss on Atherosclerotic Cardiovascular Disease Risk in Patients with Obesity [J]. Chinese General Practice, 2025, 28(26): 3229-3239. |
[6] | HU Jieman, TAN Feixiang, YUAN Anxin, CHEN Shiyu, TANG Chulei, YIN Yueheng, BA Lei, XU Qin. Analysis of the Trajectory of Postoperative Frailty and Influencing Factors in Patients with Colorectal Cancer [J]. Chinese General Practice, 2025, 28(26): 3276-3282. |
[7] | TANG Shangfeng, HUANG Yangzhen, ZHENG Yanxi, PAN Yangyang, XIONG Zhongbao, QING Hua, SONG Jia, WEI Yilin, DONG Heng, WANG Chunying, CHEN Manwei, ZHANG Kangkang. Specification for the Integration of Healthcare and Prevention Services in Diabetes at the Primary Level [J]. Chinese General Practice, 2025, 28(25): 3096-3103. |
[8] | YAN Fanghong, PENG Guotian, ZHANG Guoli, SUN Ruiyi, MA Yuxia, HAN Lin. Matching Analysis of the Content of Chronic Disease Management for the Elderly in Medical Union: Based on the Perspective of "Guidance-Practice-Need" [J]. Chinese General Practice, 2025, 28(25): 3119-3126. |
[9] | FAN Boyang, ZHANG Yu, SUN Wenning, ZHANG Huifang, WANG Yingjie, ZHANG Ao, ZHAO Yang, WANG Haipeng. Study of Behavioral Intention and Influencing Factors of Integrated Medical and Preventive Care Provided by Grassroots Doctors for Patients with Chronic Diseases [J]. Chinese General Practice, 2025, 28(25): 3144-3150. |
[10] | YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058. |
[11] | WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening. Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention [J]. Chinese General Practice, 2025, 28(24): 2985-2992. |
[12] | LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong. Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment [J]. Chinese General Practice, 2025, 28(24): 3072-3078. |
[13] | LIU Yueying, WANG Xueli, LIU Yuqiu, WEI Limin. Correlation of Fasting C-peptide to Diabetes Duration Ration and Type 2 Diabetes Mellitus Combined with Metabolism-related Fatty Liver Disease [J]. Chinese General Practice, 2025, 28(23): 2852-2860. |
[14] | BAI Xue, CHEN Qianqian, LI Jie. Innovative Practices in Chronic Disease Management: a New Model for Generalist-Specialist Combination Management of Diabetes and Metabolic Dysfunction-associated Fatty Liver Disease [J]. Chinese General Practice, 2025, 28(23): 2841-2845. |
[15] | WANG Peng, QIU Lixia, XU Shanshan, ZHANG Yang, ZHANG Jing, DU Xiaofei. Advances in the Co-management of Metabolism Dysfunction-associated Fatty Liver Disease and Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(23): 2846-2851. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||